금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
EIA Shows Crude Oil Inventories Still Rising
Crude oil inventories in the United States saw a massive increase of 4.4 million barrels during the ...
United States Dollar Index falls as US Treasury doubles long-dated debt buybacks
The US Dollar Index (DXY) comes under fresh selling pressure on Wednesday as longer-term US Treasury...
Fed Minutes expected to shed light on the depth of FOMC hawkish split
The United States (US) Federal Reserve (Fed) will release the Minutes of the July Federal Open Marke...
Powell Industries plunges 13% following Q3 miss; backlog hits record $2.4B
BWXT targets $4.70-$4.80 EPS and raises 2026 free cash flow outlook to $345M-$360M amid medical sale
If a Bear Market Is Coming, I'm Buying This 1 ETF Hand Over Fist
The Schwab U.S. Dividend Equity ETF won't be perfect in a bear market, but it can provide some buffering if stocks turn south.
People Incorporated misses Q2 topline estimates
Clorox, Vita Coco leads bearish bets in consumer staples at the start of August
Silicon Labs unveils BG2B low-power bluetooth SoC for IoT devices
3 Healthcare Stocks We Find Risky
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks hav ...
3 Reasons AVO is Risky and 1 Stock to Buy Instead
Over the last six months, Mission Produce’s shares have sunk to $12.61, producing a disappointing 6.7% loss - a stark contrast to the S&P 500’s 8.3% gain. This was partly due to its softer quarterly r ...
3 Big Reasons to Love Netflix (NFLX)
Over the past six months, Netflix’s shares (currently trading at $71.76) have posted a disappointing 10.2% loss, well below the S&P 500’s 8.3% gain. This was partly due to its softer quarterly results ...
Clorox outlines $200m+ inflation and 11%-13% free cash flow target for fiscal 2027
EPA grants biofuel exemption to Delek refinery, declines HF Sinclair petitions
Investing in the "Magnificent Seven?" Pick Your Poison: Negative Free Cash Flow or an Unjustifiable Valuation.
Wall Street's Magnificent Seven -- Apple, Nvidia, Alphabet, Microsoft, Amazon, Meta Platforms, and Tesla -- are quickly losing their luster.